1. Home
  2. SOPA vs REVB Comparison

SOPA vs REVB Comparison

Compare SOPA & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPA
  • REVB
  • Stock Information
  • Founded
  • SOPA 2018
  • REVB 2020
  • Country
  • SOPA Singapore
  • REVB United States
  • Employees
  • SOPA N/A
  • REVB N/A
  • Industry
  • SOPA EDP Services
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOPA Technology
  • REVB Health Care
  • Exchange
  • SOPA Nasdaq
  • REVB Nasdaq
  • Market Cap
  • SOPA 3.8M
  • REVB 2.8M
  • IPO Year
  • SOPA 2021
  • REVB N/A
  • Fundamental
  • Price
  • SOPA $1.26
  • REVB $3.18
  • Analyst Decision
  • SOPA Strong Buy
  • REVB
  • Analyst Count
  • SOPA 1
  • REVB 0
  • Target Price
  • SOPA $14.00
  • REVB N/A
  • AVG Volume (30 Days)
  • SOPA 1.2M
  • REVB 49.8K
  • Earning Date
  • SOPA 05-19-2025
  • REVB 05-08-2025
  • Dividend Yield
  • SOPA N/A
  • REVB N/A
  • EPS Growth
  • SOPA N/A
  • REVB N/A
  • EPS
  • SOPA N/A
  • REVB N/A
  • Revenue
  • SOPA $7,105,530.00
  • REVB N/A
  • Revenue This Year
  • SOPA $26.32
  • REVB N/A
  • Revenue Next Year
  • SOPA N/A
  • REVB N/A
  • P/E Ratio
  • SOPA N/A
  • REVB N/A
  • Revenue Growth
  • SOPA N/A
  • REVB N/A
  • 52 Week Low
  • SOPA $0.65
  • REVB $2.36
  • 52 Week High
  • SOPA $6.75
  • REVB $60.80
  • Technical
  • Relative Strength Index (RSI)
  • SOPA 63.28
  • REVB 54.29
  • Support Level
  • SOPA $1.01
  • REVB $2.87
  • Resistance Level
  • SOPA $1.33
  • REVB $3.09
  • Average True Range (ATR)
  • SOPA 0.15
  • REVB 0.24
  • MACD
  • SOPA 0.06
  • REVB 0.03
  • Stochastic Oscillator
  • SOPA 54.50
  • REVB 48.39

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with entrepreneurs, the company meets the growing demand for services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Corporate. The company generates the majority of its revenue from the Digital marketing segment.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: